Keyphrases
Abdominal Symptoms
10%
Adenoma
9%
Analytical Performance Specifications
15%
Angiotensin-converting Enzyme
9%
Angiotensin-converting Enzyme Gene
6%
Angiotensin-converting Enzyme Inhibitor (ACEi)
6%
Bowel Screening
25%
Chronic Heart Failure
5%
Clinical Outcomes
7%
Colonoscopy
28%
Colorectal Cancer
52%
Colorectal Cancer Mortality
5%
Colorectal Cancer Risk
5%
Colorectal Cancer Screening
53%
Colorectal Disease
8%
Colorectal Neoplasms
6%
Concentration Limit
8%
Deprivation
13%
Enzyme Activity
11%
Faecal Haemoglobin
37%
Faecal Immunochemical Tests for Haemoglobin
40%
Fecal Hemoglobin Concentration
65%
Fecal Immunochemical Test
89%
Fecal Occult Blood Test
24%
Fecal Test
9%
Feces
25%
Genotype
8%
Guaiac Faecal Occult Blood Test
23%
Guaiacol
9%
Hemoglobin
9%
High-risk Adenoma
6%
Interval Cancer
14%
Lower Abdomen
10%
Non-adherence
8%
OC-Sensor
5%
Patient Assessment
14%
Polymorphism
6%
Population Screening
18%
Population-based
8%
Positive Predictive Value
7%
Positivity Rate
5%
Primary Care
18%
Reference Change Value
12%
Scotland
8%
Scottish
21%
Screening Program
36%
Serum Angiotensin Converting Enzyme
9%
Significant Bowel Disease
6%
Symptomatic Patients
17%
Test Positivity
8%
Medicine and Dentistry
Adenoma
13%
Bowel Cancer Screening
6%
Cancer
10%
Colonoscopy
24%
Colorectal Cancer Screening
25%
Colorectal Carcinoma
53%
Colorectal Disease
6%
Colorectal Tumor
5%
Dipeptidyl Carboxypeptidase
6%
Diseases
6%
Enteropathy
8%
Feces
20%
Guaiacum
22%
Hemoglobin Determination
43%
Inflammatory Bowel Disease
5%
Malignant Neoplasm
10%
Mass Screening
9%
Neoplasm
9%
Observational Study
7%
Occult Blood Test
100%
Patient Referral
6%
Primary Health Care
17%
Randomized Controlled Trial
5%
Screening Test
5%
Nursing and Health Professions
Adenoma
11%
Cancer Diagnosis
5%
Cancer Screening
24%
Clinical Outcome
6%
Colonoscopy
20%
Colorectal Carcinoma
57%
Colorectal Disease
6%
Colorectal Tumor
5%
Enteropathy
8%
Guaiac
20%
Hemoglobin Determination
41%
Malignant Neoplasm
10%
Neoplasm
6%
Occult Blood
25%
Occult Blood Test
82%
Patient Referral
6%
Predictive Value
6%
Primary Medical Care
12%
